Nathan L. Mata - 18 Mar 2026 Form 3 Insider Report for BELITE BIO, INC (BLTE)

Role
Chief Scientific Officer
Signature
/s/ NATHAN L. MATA
Issuer symbol
BLTE
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 14:45:49 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MATA NATHAN L. Chief Scientific Officer 7708 MARKER ROAD, SAN DIEGO /s/ NATHAN L. MATA 18 Mar 2026 0002013987

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BLTE American depositary share 16,666 18 Mar 2026 Direct F1
holding BLTE Ordinary Share 16,666 18 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BLTE Stock Option (right to buy) 18 Mar 2026 Ordinary Shares 123,066 $6.00 Direct F2
holding BLTE Stock Option (right to buy) 18 Mar 2026 Ordinary Shares 100,000 $14.45 Direct F3
holding BLTE Stock Option (right to buy) 18 Mar 2026 Ordinary Shares 100,000 $48.46 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the Issuer.
F2 The option to purchase 123,066 ordinary shares had vested prior to March 18, 2026.
F3 The option shall vest (i) as to 50,000 ordinary shares on July 17, 2023, and (ii) as to 50,000 ordinary shares in 36 equal and continuous monthly installments for each full month of services completed following July 17, 2023, subject to continued service to the Issuer on each such date.
F4 The option shall vest as to 100,000 ordinary shares in 36 equal and continue monthly installments for each full month of services completed following August 29, 2024, subject to continued service to the Issuer on such date.

Remarks:

Exhibit 24 - Power of Attorney